Structural mutations in cancer: Mechanistic and functional insights

Trends in Genetics

Volumn 28, Issue 11, 2012, Pages 550-559

  Inaki, Koichiro ^a,b   Liu, Edison T ^a,b  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b JACKSON LABORATORY   (United States)

Author keywords

Cancer genome; Chromosome structure; Genomic rearrangement; Mutational mechanisms; Structural mutation; Tandem duplication

Indexed keywords

DNA;

CANCER CELL CULTURE; CANCER GENETICS; CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME INVERSION; CHROMOSOME STRUCTURE; CHROMOSOME TRANSLOCATION; CHROMOTHRIPSIS; COPY NUMBER VARIATION; FUSION GENE; GENE AMPLIFICATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ORGANIZATION; GENETIC TRANSCRIPTION; GENOME; HUMAN; MOLECULAR EVOLUTION; ONCOGENE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION;

ANIMALS; GENOME, HUMAN; HUMANS; MUTATION; NEOPLASMS; ONCOGENES;

EID: 84867716702     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2012.07.002     Document Type: Review

References (85)

1. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
2. Mitelman F., et al. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat. Genet. 2004, 36:331-334.
3. Mitelman F., et al. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer 2007, 7:233-245.
4. Mardis E.R. The impact of next-generation sequencing technology on genetics. Trends Genet. 2008, 24:133-141.
5. Lizardi P.M., et al. Genome-wide approaches for cancer gene discovery. Trends Biotechnol. 2011, 29:558-568.
6. Weir B.A., et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007, 450:893-898.
7. Baudis M., et al. Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data. BMC Cancer 2007, 7:226.
8. Janoueix-Lerosey I., et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 2008, 455:967-970.
9. Bignell G.R., et al. Signatures of mutation and selection in the cancer genome. Nature 2010, 463:893-898.
10. Beroukhim R., et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463:899-905.
11. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068.
12. Taylor B.S., et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010, 18:11-22.
13. Cancer Genome Atlas Research Network (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615.
14. Greenman C., et al. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158.
15. Ding L., et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008, 455:1069-1075.
16. Kan Z., et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 2010, 466:869-873.
17. Jones S., et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008, 321:1801-1806.
18. Wood L.D., et al. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
19. Campbell P.J., et al. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat. Genet. 2008, 40:722-729.
20. Stephens P.J., et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 2009, 462:1005-1010.
21. Pleasance E.D., et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010, 463:184-190.
22. Pleasance E.D., et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010, 463:191-196.
23. Lee W., et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 2010, 465:473-477.
24. Ding L., et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010, 464:999-1005.
25. Campbell P.J., et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010, 467:1109-1113.
26. Stephens P.J., et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011, 144:27-40.
27. Berger M.F., et al. The genomic complexity of primary human prostate cancer. Nature 2011, 470:214-220.
28. Hillmer A.M., et al. Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes. Genome Res. 2011, 21:665-675.
29. Totoki Y., et al. High-resolution characterization of a hepatocellular carcinoma genome. Nat. Genet. 2011, 43:464-469.
30. Chapman M.A., et al. Initial genome sequencing and analysis of multiple myeloma. Nature 2011, 471:467-472.
31. Puente X.S., et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011, 475:101-105.
32. Bass A.J., et al. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat. Genet. 2011, 43:964-968.
33. Inaki K., et al. Transcriptional consequences of genomic structural aberrations in breast cancer. Genome Res. 2011, 21:676-687.
34. Rabbitts T.H. Commonality but diversity in cancer gene fusions. Cell 2009, 137:391-395.
35. Taki T., Taniwaki M. Chromosomal translocations in cancer and their relevance for therapy. Curr. Opin. Oncol. 2006, 18:62-68.
36. Soda M., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
37. Rikova K., et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131:1190-1203.
38. Lin E., et al. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers. Mol. Cancer Res. 2009, 7:1466-1476.
39. Kwak E.L., et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 2010, 363:1693-1703.
40. Prensner J.R., Chinnaiyan A.M. Oncogenic gene fusions in epithelial carcinomas. Curr. Opin. Genet. Dev. 2009, 19:82-91.
41. Tognon C., et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002, 2:367-376.
42. Li Z., et al. ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. Cancer Cell 2007, 12:542-558.
43. Palanisamy N., et al. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat. Med. 2010, 16:793-798.
44. Nakamura T. NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins. Int. J. Hematol. 2005, 82:21-27.
45. Tomlins S.A., et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005, 310:644-648.
46. Tomlins S.A., et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007, 448:595-599.
47. Helgeson B.E., et al. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Cancer Res. 2008, 68:73-80.
48. Tomlins S.A., et al. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 2008, 10:177-188.
49. Clark J.P., Cooper C.S. ETS gene fusions in prostate cancer. Nat. Rev. Urol. 2009, 6:429-439.
50. Graux C., et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat. Genet. 2004, 36:1084-1089.
51. Basecke J., et al. The MLL partial tandem duplication in acute myeloid leukaemia. Br. J. Haematol. 2006, 135:438-449.
52. Meshinchi S., Appelbaum F.R. Structural and functional alterations of FLT3 in acute myeloid leukemia. Clin. Cancer Res. 2009, 15:4263-4269.
53. Ng C.K., et al. The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer. J. Pathol. 2012, 226:703-712.
54. Magrangeas F., et al. Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients. Blood 2011, 118:675-678.
55. Kloosterman W.P., et al. Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer. Genome Biol. 2011, 12:R103.
56. Crasta K., et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 2012, 482:53-58.
57. Hastings P.J., et al. Mechanisms of change in gene copy number. Nat. Rev. Genet. 2009, 10:551-564.
58. Lieber M.R. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu. Rev. Biochem. 2010, 79:181-211.
59. Branzei D., Foiani M. Maintaining genome stability at the replication fork. Nat. Rev. Mol. Cell Biol. 2010, 11:208-219.
60. Mani R.S., et al. Induced chromosomal proximity and gene fusions in prostate cancer. Science 2009, 326:1230.
61. Lin C., et al. Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 2009, 139:1069-1083.
62. Haffner M.C., et al. Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat. Genet. 2010, 42:668-675.
63. Aguilera A., Gómez-González B. Genome instability: a mechanistic view of its causes and consequences. Nat. Rev. Genet. 2008, 9:204-217.
64. Chiarle R., et al. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell 2011, 147:107-119.
65. Klein I.A., et al. Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 2011, 147:95-106.
66. Roix J.J., et al. Spatial proximity of translocation-prone gene loci in human lymphomas. Nat. Genet. 2003, 34:287-291.
67. Osborne C.S., et al. Myc dynamically and preferentially relocates to a transcription factory occupied by Igh. PLoS Biol. 2007, 5:e192.
68. Fullwood M.J., et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009, 462:58-64.
69. Bermejo R., et al. Genome-organizing factors Top2 and Hmo1 prevent chromosome fragility at sites of S phase transcription. Cell 2009, 138:870-884.
70. Phillips J.E., Corces V.G. CTCF: master weaver of the genome. Cell 2009, 137:1194-1211.
71. Handoko L., et al. CTCF-mediated functional chromatin interactome in pluripotent cells. Nat. Genet. 2011, 43:630-638.
72. Song L., et al. Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res. 2011, 21:1757-1767.
73. Cayrou C., et al. Programming DNA replication origins and chromosome organization. Chromosome Res. 2010, 18:137-145.
74. Guillou E., et al. Cohesin organizes chromatin loops at DNA replication factories. Genes Dev. 2010, 24:2812-2822.
75. Sequeira-Mendes J., et al. Transcription initiation activity sets replication origin efficiency in mammalian cells. PLoS Genet. 2009, 5:e1000446.
76. Valenzuela M.S., et al. Preferential localization of human origins of DNA replication at the 5'-ends of expressed genes and at evolutionarily conserved DNA sequences. PLoS ONE 2011, 6:e17308.
77. Blow J.J., Gillespie P.J. Replication licensing and cancer: a fatal entanglement?. Nat. Rev. Cancer 2008, 8:799-806.
78. Hook S.S., et al. Mechanisms to control rereplication and implications for cancer. Curr. Opin. Cell Biol. 2007, 19:663-671.
79. Green B.M., et al. Loss of DNA replication control is a potent inducer of gene amplification. Science 2010, 329:943-946.
80. Larkin D.M., et al. Breakpoint regions and homologous synteny blocks in chromosomes have different evolutionary histories. Genome Res. 2009, 19:770-777.
81. Stott F.J., et al. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 1998, 17:5001-5014.
82. Bates S., et al. p14ARF links the tumour suppressors RB and p53. Nature 1998, 395:124-125.
83. Ozery-Flato M., et al. Large-scale analysis of chromosomal aberrations in cancer karyotypes reveals two distinct paths to aneuploidy. Genome Biol. 2011, 12:R61.
84. Yachida S., et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010, 467:1114-1117.
85. Navin N., et al. Tumour evolution inferred by single-cell sequencing. Nature 2011, 472:90-94.